Philip R. Muskin, MD, MA, DLFAPA, LFACLP

Phillip R. Muskin, MD, discusses the complexities of prescribing antipsychotics, emphasizing patient collaboration and the importance of evaluating treatment strategies.

Fill out this survey if you are a clinician who lactated while working.

Philip R. Muskin, MD, MA, DLFAPA, LFACLP, discusses contemporary psychiatry and some of the most exciting things about the 2024 Annual Meeting.

In patients seen in the medical setting, as many as 20% have personality disorders.

How can hospital staff provide the most effective care to patients with comorbid medical illness and serious mental illness?

Most patients have more than 1 condition that requires attention. Here's what you need to know.

The patient’s autonomy: a guiding principle.

Combining Thanksgiving, Hanukkah, and December birthday celebrations for the ultimate unique family dinner.

A simple exercise and tools to "find your Zen."

What factors lie at the heart of the patient/physician relationship?

With topics such as antidepressant treatments, brain stimulation, pharmacogenetics, and rapidly acting agents, there is something for everybody wanting to learn the latest on MDD at this year’s APA meeting.

From the treatment of mood and anxiety disorders in pregnant and nursing women to the effects of antidepressants and anti-inflammatory agents on older adults with stress and mood disorders, APA is a great opportunity to learn state-of-the-art information on bipolar disorder.

There’s a lot going on at the American Psychiatric Association Annual Meeting in the Big Apple this year . . . so much, in fact, that we’ve invited the Chair of Scientific Program Committee, Dr Philip R. Muskin, to provide you with a road map. More in this podcast.

In this brief video, Psychiatric Times’ new Editoral Board member talks about what DSM-5, the medical home, and the search for money to fund novel approaches to new psychiatric treatments may mean to the practice of psychiatry.